Unresectable or metastatic melanoma
Clinical trials for Unresectable or metastatic melanoma explained in plain language.
Never miss a new study
Get alerted when new Unresectable or metastatic melanoma trials appear
Sign up with your email to follow new studies for Unresectable or metastatic melanoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a Two-Drug immune combo shrink melanoma tumors?
Disease control CompletedThis phase II trial tests whether combining two immunotherapy drugs, nivolumab and relatlimab, can shrink tumors in people with metastatic melanoma who have not yet received immunotherapy. Nivolumab helps immune cells attack cancer, while relatlimab blocks a different brake on th…
Matched conditions: UNRESECTABLE OR METASTATIC MELANOMA
Phase 2 • Sponsor: John Kirkwood • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New hope for advanced melanoma: experimental drug shows promise in early trial
Disease control CompletedThis study tested two different doses of an experimental drug called RO7247669 in 93 people with advanced melanoma that had not been treated before. The goal was to see how well the drug controls the cancer and to find the best dose with the fewest side effects. Participants rece…
Matched conditions: UNRESECTABLE OR METASTATIC MELANOMA
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Needle under the skin: easier nivolumab shot studied for advanced tumors
Disease control CompletedThis study tested giving the cancer drug nivolumab as a shot under the skin (instead of through an IV) to people with advanced cancers like lung, kidney, melanoma, liver, and colorectal cancer. The main goal was to see how the drug moves in the body and to check for side effects.…
Matched conditions: UNRESECTABLE OR METASTATIC MELANOMA
Phase 1/2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC